Multiple Sclerosis Trial, Recruiting (NCT06596746)

Multiple Sclerosis Trial, Recruiting NCT06596746 Sponsor: Casa di Cura San Raffaele Cassino Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT06596746 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Parkinson's Disease (confirmed using UK Parkinson's Disease Society Brain Bank guidelines)
You have been diagnosed with Multiple System Atrophy (MSA), a condition that affects movement and automatic body functions
You have been diagnosed with Progressive Supranuclear Palsy (PSP), a condition that affects balance, movement, and eye control
You have been diagnosed with Essential Tremor, a condition that causes uncontrollable shaking
You have been diagnosed with Lewy Body Dementia, Alzheimer's Disease, Mild Cognitive Decline, or have noticed problems with your memory
You are willing to take part in the study, understand what it involves, and are able to sign a consent form

Who may not be able to join:

You are not able to complete the research assessments required by the study (confirm with trial site)

Note: There are no restrictions based on age, how severe your condition is, or whether you have memory or thinking difficulties, as long as you are able to complete the study tasks.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0776394740

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06596746

Sponsor: Casa di Cura San Raffaele Cassino

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 0776394740

More information: https://clinicaltrials.gov/study/NCT06596746

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Parkinson's Disease (confirmed using UK Parkinson's Disease Society Brain Bank guidelines)
You have been diagnosed with Multiple System Atrophy (MSA), a condition that affects movement and automatic body functions
You have been diagnosed with Progressive Supranuclear Palsy (PSP), a condition that affects balance, movement, and eye control
You have been diagnosed with Essential Tremor, a condition that causes uncontrollable shaking
You have been diagnosed with Lewy Body Dementia, Alzheimer's Disease, Mild Cognitive Decline, or have noticed problems with your memory
You are willing to take part in the study, understand what it involves, and are able to sign a consent form

Who may not be able to join:

You are not able to complete the research assessments required by the study (confirm with trial site)

Note: There are no restrictions based on age, how severe your condition is, or whether you have memory or thinking difficulties, as long as you are able to complete the study tasks.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Casa di Cura San Raffaele Cassino

Registry

ClinicalTrials.gov

Start date

9 September 2024

Est. completion

9 September 2034

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

To monitor and predict the course of neurodegenerative diseases through the study of clinical markers and the creation of AI-models

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov